Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.
This could reduce the cost of Zepbound to $168 per month. Many health insurance plans don't cover the weight loss drug Zepbound because it's so new. It was approved by the FDA at the end of 2023 ...
A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
A taurine-derived metabolite may hold the key to regulating food intake and body weight, potentially inspiring a new class of ...